5 mg
Trade Name
Lynxelin
Film-coated tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:
monotherapy
• When metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.
combination therapy
• In combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
monotherapy
• When metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.
combination therapy
• In combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.